Chi­nese on­col­o­gy spe­cial­ist Zai Lab bro­kers a deal with Macro­Gen­ics for up to 4 bis­pecifics with a mod­est down pay­ment

Saman­tha Du’s Zai Lab has earned its rep­u­ta­tion as a Chi­nese on­col­o­gy part­ner of choice with an ag­gres­sive li­cens­ing strat­e­gy to tap that grow­ing mar­ket …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER